Titan Pharmaceuticals, Inc. (TTNP) Financials
TTNP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 10.0 million | 1.9 million |
| 2023-06-30 | 812000 | 1.8 million |
| 2023-03-31 | 2.2 million | 2.5 million |
| 2022-12-31 | 4.1 million | 2.7 million |
TTNP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.8 million | 411000 |
| 2023-06-30 | -1.1 million | 264000 |
| 2023-03-31 | -1.9 million | 290000 |
| 2022-12-31 | -1.6 million | -91000 |
TTNP Net Income
No data available :(
TTNP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 8.1 million | - | 97000 |
| 2023-06-30 | 105000 | - | 128000 |
| 2023-03-31 | 1.1 million | - | 158000 |
| 2022-12-31 | 2.9 million | - | 187000 |
TTNP Shares Outstanding
TTNP Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 424000 | 1.6 million | - |
| 2023-06-30 | - | 442000 | 1.2 million | - |
| 2023-03-31 | - | 561000 | 1.2 million | - |
| 2022-12-31 | - | 1.4 million | 1.3 million | - |
TTNP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 4000 | 27000 |
| 2023-06-30 | 1000 | 442000 |
| 2023-03-31 | 98000 | 43000 |
| 2022-12-31 | 51000 | 45000 |
TTNP
Price: $6.88
52 week price:
Earnings Per Share: -7.41 USD
P/E Ratio: -0.88
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 35000
Ebitda: -4.0 millionMarket Capitalization: 6.6 million